Home > Business, Equities, Round Up > Research Oracle roundup for 02 November 2009

Research Oracle roundup for 02 November 2009

November 2nd, 2009 Suraj Leave a comment Go to comments

Earning Release

AngloGold Ashanti Limited (NYSE:AU) reported an increase in revenues y-o-y, driven by higher average gold price realization. Although underlying bottom-line benefited from a decline in the cost of sales as a percentage of revenues, the company reported a significant net loss, largely reflecting its hedging activities. We maintain the ADR rating a SELL at current levels. We will reassess our ADR rating in our next update report. We continue to anticipate a negative currency impact on the South African stock (1 ADR = 1 South African share) over the coming 6-12 months. Therefore, we maintain our SELL rating. We will reassess our South African stock rating in our next update report.

Patni Computer Systems Limited (NYSE:PTI) reported its second consecutive sequential revenue growth performance in 3Q 09, pointing towards a stabilized demand environment, much like its peers in the Indian IT services industry. Although y-o-y revenues continue to be lower, the rate of decline is slowing, as can be seen from the company's 4Q 09 top-line guidance. Whilst higher utilization and cost reduction measures resulted in improved y-o-y adjusted operating profitability, sequential performance disappointed. New client additions remained mute and witnessed a reduction on both a sequential as well as y-o-y basis, as did employee additions. 4Q 09 guidance suggests flattish to marginal q-o-q revenue growth. Although we believe the worst is over for the Indian IT services sector, particularly on the demand front, we are moderating our rating for the Patni ADR given the significant run-up in the stock price since our previous update report as we believe the market has already factored in expectations of a rebound in the sector. We will reassess our estimates and target price for Patni's ADR in the following weeks. We had rated the Patni Indian stock a SELL on anticipation of a negative currency impact over the next 6-12 months. However, given the significant run-up in stock price since our previous rating and considering our fundamental rating, we rate the Indian stock a HOLD until we reassess our rating and target price in the coming weeks.

News

Coca-Cola FEMSA, S.A.B. de C.V.'s (NYSE:KOF) common stock has appreciated significantly since our previous update, closing at MXN71.26. The increase primarily reflected positive investor sentiment relating to the possible synergistic benefits arising from the merger with Fomento Económico Mexicano, S.A.B. de C.V.'s (FEMSA) underperforming beer business. In light of proposed synergy benefits and as KOF's results were broadly above our estimates, we expect to revise our estimates and target price upwards. As a result, although the target price does not support a HOLD rating we reiterate the common stock a HOLD and will reassess our target price and rating in our 3Q 09 update report. As we expect significant positive currency impact on the ADR over our 6-24 month investment horizon and since the target price supports a BUY we maintain our BUY rating for the ADR (1 ADR = 10 common shares). We will reassess our target price and rating in our 3Q 09 update report.

From September 2009, the Research Oracle will begin to accept research submissions from readers – whether amateur or professional analysts – from around the globe. To receive notification of the launch and rules, contributors may register now at
http://www.iirgroup.com/researchoracle/researchoracleaward

Read the full reports free of charge with free to view access to institutional-quality research on 400 companies and over 700 stocks at www.researchoracle.com

”Become

”Buy

Important information for US investors.

With the ending of the Spitzer settlement in July 2009 there will be a dramatic reduction of free independent research available to investors like yourself. Although this will not impact the Research Oracle, we believe that freely available independent research is crucial for a healthy market to function. Ask your broker a/e what plans they expect to implement to continue to provide you with independent research. You may wish to read this recent coverage from TIME Magazine for more information.
Copyright © 2009 Independent International Investment Research PLC. All rights reserved.

http://www.time.com/time/business/article/0,8599,1893519,00.html

399 views.

Categories: Business, Equities, Round Up Tags: , ,
  1. No comments yet.
  1. No trackbacks yet.
Business Directory for London, London
399